Supporting this hypothesis, Mitobe et al. (2020) demonstrated that in MCF-7 breast cancer cells, knockdown of polypyrimidine tract-binding protein-associated splicing factor (PSF) significantly suppressed ESR1 mRNA expression and ERα protein levels in a post-transcriptional manner, consequently repressing proliferation [36]. The gene discussed is ESR1; the disease is breast carcinoma.